TThis paper presents an assessment of the awareness of final year students of the pediatric faculty of Kursk State Medical University (KSMU) about the tactics of diagnosis and treatment of atopic dermatitis using an anonymous survey of 56 students in the Goggle Forms program.
53.6% of students correctly indicated the age limits of the infant form of blood pressure; 46.4% chose the wrong answer. According to future doctors, a patient with AD must be observed by a pediatrician (96.4%) and an allergist-immunologist (98.2%), while a dermatologist is given a secondary role in deciding on the treatment of the child (33.9%). According to 58.9% of students, atopic dermatitis is always combined with food allergies, which is an erroneous opinion. 17.9% of students believe that there is not always a direct connection between blood pressure and food allergies, and 23.2% of students found it difficult to answer this question. 35.7% of students chose systemic corticosteroids as a mandatory component of active external therapy, 41.1% voted for the use of topical corticosteroids, 8.9% believed that an elimination diet was necessary during treatment, and 14.3% chose the use of emollients as mandatory component of the treatment regimen.
  Analyzing the results of the survey, we can say that students of Kursk Medical University are sufficiently informed about such a disease as atopic dermatitis: most students are well versed in the classification of blood pressure, methods of diagnosis and interpretation of the data obtained, the choice of drugs for treatment, and what specialties doctors should observe a child with HELL. But it should also be noted that a number of students had difficulties in the question of whether atopic dermatitis is always combined with food allergies, and 45.5% had a misunderstanding of the purpose of the SCORAD scale.

Diabetes mellitus type 2 (type 2 diabetes) is generally recognized as one of the non-infectious pandemics of modern humanity. The results of international studies indicate that more than 500 million people suffer from this disease throughout the planet; Unfortunately, the current trend tends to increase the number of new cases of newly diagnosed type 2 diabetes: in the next 30 years, the proportion of patients with this disease in the general population may double again. Aim. To study the structure and frequency of prescription of sodium-glucose cotransporter type 2 inhibitors (NGLT-2 inhibitors) in patients with type 2 diabetes mellitus (DM) in the endocrinology department of one of the hospitals in Kursk for the period July - December 2023. Materials and methods. Using a continuous sampling method, the medical records of 297 patients with type 2 diabetes who were under observation in the endocrinology department of one of the hospitals in Kursk from July to December 2023 were analyzed. Results. The total number of prescriptions for oral glycemic drugs was 583, of which 121 (20.8%) were in the group of SGLT-2 inhibitors. 13.7% accounted for dapagliflozin, 6.2% for empagliflozin, 0.9% for ipragliflozin (of the total number of prescriptions, respectively). The intragroup structure of prescriptions for this class of drugs was represented by empagliflozin (29.8%), dapagliflozin (66.1%), and ipragliflozin (4.1%, respectively). Canagliflozin and ertugliflozin were not used in hospital settings. The frequency of use of these drugs among inpatients (n = 297) was: 26.9% for dapagliflozin, 12.1% for empagliflozin and 1.7% for ipragliflozin, respectively. Conclusion. Currently, the use of SGLT-2 inhibitors is recommended by both national and international guidelines and protocols for the management of patients with type 2 diabetes; therefore, they (in particular, empagliflozin and dapagliflozin) occupy one of the leading positions in real clinical practice - in general, and in hospital settings - in particular.